| ENSG00000175701.6 |
Imatinib |
Breast invasive carcinoma |
0.042004991 |
Resistant |
| ENSG00000197813.4 |
Imatinib |
Breast invasive carcinoma |
0.004751099 |
Resistant |
| ENSG00000228436.2 |
Imatinib |
Breast invasive carcinoma |
0.039708054 |
Resistant |
| ENSG00000229660.1 |
Imatinib |
Breast invasive carcinoma |
0.032636765 |
Resistant |
| ENSG00000231187.2 |
Imatinib |
Breast invasive carcinoma |
0.020307513 |
Resistant |
| ENSG00000233878.1 |
Imatinib |
Breast invasive carcinoma |
0.048798643 |
Resistant |
| ENSG00000233895.1 |
Imatinib |
Breast invasive carcinoma |
0.001993691 |
Resistant |
| ENSG00000235590.3 |
Imatinib |
Breast invasive carcinoma |
0.021074059 |
Resistant |
| ENSG00000236743.1 |
Imatinib |
Breast invasive carcinoma |
0.037160896 |
Resistant |
| ENSG00000243368.2 |
Imatinib |
Breast invasive carcinoma |
0.043862687 |
Resistant |
| ENSG00000244541.1 |
Imatinib |
Breast invasive carcinoma |
0.037945505 |
Resistant |
| ENSG00000253174.2 |
Imatinib |
Breast invasive carcinoma |
0.017898609 |
Resistant |
| ENSG00000253671.1 |
Imatinib |
Breast invasive carcinoma |
0.025037453 |
Resistant |
| ENSG00000256312.1 |
Imatinib |
Breast invasive carcinoma |
0.007334203 |
Resistant |
| ENSG00000256897.1 |
Imatinib |
Breast invasive carcinoma |
0.022632144 |
Resistant |
| ENSG00000257086.1 |
Imatinib |
Breast invasive carcinoma |
0.014099398 |
Resistant |
| ENSG00000260368.1 |
Imatinib |
Breast invasive carcinoma |
0.032917069 |
Resistant |
| ENSG00000262094.1 |
Imatinib |
Breast invasive carcinoma |
0.03775117 |
Resistant |
| ENSG00000264575.1 |
Imatinib |
Breast invasive carcinoma |
0.010106425 |
Resistant |
| ENSG00000267519.2 |
Imatinib |
Breast invasive carcinoma |
0.030054757 |
Resistant |
| ENSG00000272558.1 |
Imatinib |
Breast invasive carcinoma |
0.010106256 |
Resistant |
| ENSG00000132832.5 |
Imatinib |
Esophageal cancer |
0.045673561 |
Resistant |
| ENSG00000223764.2 |
Imatinib |
Esophageal cancer |
0.030699157 |
Resistant |
| ENSG00000225914.1 |
Imatinib |
Esophageal cancer |
0.008671688 |
Resistant |
| ENSG00000231948.2 |
Imatinib |
Esophageal cancer |
0.041549837 |
Resistant |
| ENSG00000232618.1 |
Imatinib |
Esophageal cancer |
0.039482201 |
Resistant |
| ENSG00000234418.1 |
Imatinib |
Esophageal cancer |
0.036763292 |
Resistant |
| ENSG00000234571.1 |
Imatinib |
Esophageal cancer |
0.020823997 |
Resistant |
| ENSG00000235138.1 |
Imatinib |
Esophageal cancer |
0.040354404 |
Resistant |
| ENSG00000236423.1 |
Imatinib |
Esophageal cancer |
0.019882636 |
Resistant |
| ENSG00000240350.1 |
Imatinib |
Esophageal cancer |
0.004179983 |
Resistant |
| ENSG00000243902.2 |
Imatinib |
Esophageal cancer |
0.043630698 |
Resistant |
| ENSG00000250889.2 |
Imatinib |
Esophageal cancer |
0.018935409 |
Resistant |
| ENSG00000255992.1 |
Imatinib |
Esophageal cancer |
0.012737071 |
Resistant |
| ENSG00000258983.1 |
Imatinib |
Esophageal cancer |
0.010224837 |
Resistant |
| ENSG00000259209.1 |
Imatinib |
Esophageal cancer |
0.046242122 |
Resistant |
| ENSG00000260329.1 |
Imatinib |
Esophageal cancer |
0.044699672 |
Resistant |
| ENSG00000260630.2 |
Imatinib |
Esophageal cancer |
0.016504277 |
Resistant |
| ENSG00000264812.1 |
Imatinib |
Esophageal cancer |
0.006121811 |
Resistant |
| ENSG00000266936.1 |
Imatinib |
Esophageal cancer |
0.01956853 |
Resistant |
| ENSG00000267093.1 |
Imatinib |
Esophageal cancer |
0.018792394 |
Resistant |
| ENSG00000267372.1 |
Imatinib |
Esophageal cancer |
0.038397077 |
Resistant |
| ENSG00000267491.1 |
Imatinib |
Esophageal cancer |
0.012070283 |
Resistant |
| ENSG00000269976.1 |
Imatinib |
Esophageal cancer |
0.011192459 |
Resistant |
| ENSG00000273342.1 |
Imatinib |
Esophageal cancer |
0.004289985 |
Resistant |
| ENSG00000273402.1 |
Imatinib |
Esophageal cancer |
0.021962207 |
Resistant |
| ENSG00000224307.1 |
Imatinib |
Brain lower grade glioma |
0.044624685 |
Resistant |
| ENSG00000225328.1 |
Imatinib |
Brain lower grade glioma |
0.041049862 |
Resistant |
| ENSG00000229512.1 |
Imatinib |
Brain lower grade glioma |
0.044473363 |
Resistant |
| ENSG00000229915.1 |
Imatinib |
Brain lower grade glioma |
0.034825425 |
Resistant |
| ENSG00000230641.1 |
Imatinib |
Brain lower grade glioma |
0.031688989 |
Resistant |
| ENSG00000231789.2 |
Imatinib |
Brain lower grade glioma |
0.027795363 |
Resistant |
| ENSG00000231999.2 |
Imatinib |
Brain lower grade glioma |
0.034989122 |
Resistant |
| ENSG00000233621.1 |
Imatinib |
Brain lower grade glioma |
0.014604035 |
Resistant |
| ENSG00000233845.1 |
Imatinib |
Brain lower grade glioma |
0.011897798 |
Resistant |
| ENSG00000234694.1 |
Imatinib |
Brain lower grade glioma |
0.045254232 |
Resistant |
| ENSG00000234807.4 |
Imatinib |
Brain lower grade glioma |
0.03291271 |
Resistant |
| ENSG00000235209.1 |
Imatinib |
Brain lower grade glioma |
0.032910712 |
Resistant |
| ENSG00000236914.3 |
Imatinib |
Brain lower grade glioma |
0.022460135 |
Resistant |
| ENSG00000237852.1 |
Imatinib |
Brain lower grade glioma |
0.001509521 |
Resistant |
| ENSG00000241990.1 |
Imatinib |
Brain lower grade glioma |
0.031809073 |
Resistant |
| ENSG00000243637.1 |
Imatinib |
Brain lower grade glioma |
0.035370739 |
Resistant |
| ENSG00000250250.1 |
Imatinib |
Brain lower grade glioma |
0.038539639 |
Resistant |
| ENSG00000253917.3 |
Imatinib |
Brain lower grade glioma |
0.016192461 |
Resistant |
| ENSG00000261798.1 |
Imatinib |
Brain lower grade glioma |
0.043378612 |
Resistant |
| ENSG00000267201.1 |
Imatinib |
Brain lower grade glioma |
0.040952187 |
Resistant |
| ENSG00000271314.1 |
Imatinib |
Brain lower grade glioma |
0.02024148 |
Resistant |
| ENSG00000272009.1 |
Imatinib |
Brain lower grade glioma |
0.036897109 |
Resistant |
| ENSG00000272702.1 |
Imatinib |
Brain lower grade glioma |
0.007993165 |
Resistant |
| ENSG00000272950.1 |
Imatinib |
Brain lower grade glioma |
0.017844323 |
Resistant |
| ENSG00000196553.9 |
Imatinib |
Lung squamous cell carcinoma |
0.006124278 |
Resistant |
| ENSG00000205890.3 |
Imatinib |
Lung squamous cell carcinoma |
0.031198987 |
Resistant |
| ENSG00000224985.1 |
Imatinib |
Lung squamous cell carcinoma |
0.036804918 |
Resistant |
| ENSG00000226380.3 |
Imatinib |
Lung squamous cell carcinoma |
0.037683792 |
Resistant |
| ENSG00000227646.3 |
Imatinib |
Lung squamous cell carcinoma |
0.042194208 |
Resistant |
| ENSG00000227959.1 |
Imatinib |
Lung squamous cell carcinoma |
0.004675373 |
Resistant |
| ENSG00000229140.4 |
Imatinib |
Lung squamous cell carcinoma |
0.030795797 |
Resistant |
| ENSG00000229444.1 |
Imatinib |
Lung squamous cell carcinoma |
0.034232721 |
Resistant |
| ENSG00000229656.2 |
Imatinib |
Lung squamous cell carcinoma |
0.00584722 |
Resistant |
| ENSG00000230534.2 |
Imatinib |
Lung squamous cell carcinoma |
0.002946597 |
Resistant |
| ENSG00000230826.1 |
Imatinib |
Lung squamous cell carcinoma |
0.032645949 |
Resistant |
| ENSG00000231092.1 |
Imatinib |
Lung squamous cell carcinoma |
0.010497062 |
Resistant |
| ENSG00000231566.1 |
Imatinib |
Lung squamous cell carcinoma |
0.017671807 |
Resistant |
| ENSG00000232445.1 |
Imatinib |
Lung squamous cell carcinoma |
0.038105072 |
Resistant |
| ENSG00000232533.1 |
Imatinib |
Lung squamous cell carcinoma |
0.042392827 |
Resistant |
| ENSG00000233237.2 |
Imatinib |
Lung squamous cell carcinoma |
0.007246191 |
Resistant |
| ENSG00000236098.1 |
Imatinib |
Lung squamous cell carcinoma |
0.000310537 |
Resistant |
| ENSG00000249664.1 |
Imatinib |
Lung squamous cell carcinoma |
0.040064786 |
Resistant |
| ENSG00000249673.2 |
Imatinib |
Lung squamous cell carcinoma |
0.036993641 |
Resistant |
| ENSG00000250106.1 |
Imatinib |
Lung squamous cell carcinoma |
0.00651095 |
Resistant |
| ENSG00000250714.3 |
Imatinib |
Lung squamous cell carcinoma |
0.048282246 |
Resistant |
| ENSG00000250900.2 |
Imatinib |
Lung squamous cell carcinoma |
0.01404376 |
Resistant |
| ENSG00000253930.1 |
Imatinib |
Lung squamous cell carcinoma |
0.02023542 |
Resistant |
| ENSG00000255921.1 |
Imatinib |
Lung squamous cell carcinoma |
0.025420526 |
Resistant |
| ENSG00000257135.1 |
Imatinib |
Lung squamous cell carcinoma |
0.022890172 |
Resistant |
| ENSG00000258344.1 |
Imatinib |
Lung squamous cell carcinoma |
0.017017323 |
Resistant |
| ENSG00000258902.1 |
Imatinib |
Lung squamous cell carcinoma |
0.039674859 |
Resistant |
| ENSG00000259782.2 |
Imatinib |
Lung squamous cell carcinoma |
0.047745486 |
Resistant |
| ENSG00000260059.1 |
Imatinib |
Lung squamous cell carcinoma |
0.014529243 |
Resistant |
| ENSG00000262228.1 |
Imatinib |
Lung squamous cell carcinoma |
0.00741401 |
Resistant |
| ENSG00000263567.1 |
Imatinib |
Lung squamous cell carcinoma |
0.041847644 |
Resistant |
| ENSG00000271228.1 |
Imatinib |
Lung squamous cell carcinoma |
0.029894456 |
Resistant |
| ENSG00000271874.1 |
Imatinib |
Lung squamous cell carcinoma |
0.049758192 |
Resistant |
| ENSG00000272702.1 |
Imatinib |
Lung squamous cell carcinoma |
0.032894541 |
Resistant |
| ENSG00000272769.1 |
Imatinib |
Lung squamous cell carcinoma |
0.005884712 |
Resistant |
| ENSG00000235884.2 |
Imatinib |
Breast invasive carcinoma |
0.041107532 |
Sensitive |
| ENSG00000253764.1 |
Imatinib |
Breast invasive carcinoma |
0.029316269 |
Sensitive |
| ENSG00000263612.1 |
Imatinib |
Breast invasive carcinoma |
0.034228263 |
Sensitive |
| ENSG00000264222.1 |
Imatinib |
Breast invasive carcinoma |
0.040679159 |
Sensitive |
| ENSG00000266970.1 |
Imatinib |
Breast invasive carcinoma |
0.048253871 |
Sensitive |
| ENSG00000272068.1 |
Imatinib |
Breast invasive carcinoma |
0.049662005 |
Sensitive |
| ENSG00000272508.1 |
Imatinib |
Breast invasive carcinoma |
0.035620646 |
Sensitive |
| ENSG00000273287.1 |
Imatinib |
Breast invasive carcinoma |
0.009168418 |
Sensitive |
| ENSG00000219665.4 |
Imatinib |
Esophageal cancer |
0.046275222 |
Sensitive |
| ENSG00000224251.2 |
Imatinib |
Esophageal cancer |
0.009544211 |
Sensitive |
| ENSG00000225075.1 |
Imatinib |
Esophageal cancer |
0.03763259 |
Sensitive |
| ENSG00000233008.1 |
Imatinib |
Esophageal cancer |
0.006101914 |
Sensitive |
| ENSG00000236743.1 |
Imatinib |
Esophageal cancer |
0.007810688 |
Sensitive |
| ENSG00000237819.1 |
Imatinib |
Esophageal cancer |
0.039947107 |
Sensitive |
| ENSG00000253174.2 |
Imatinib |
Esophageal cancer |
0.01395172 |
Sensitive |
| ENSG00000254761.1 |
Imatinib |
Esophageal cancer |
0.039192877 |
Sensitive |
| ENSG00000254812.1 |
Imatinib |
Esophageal cancer |
0.012868278 |
Sensitive |
| ENSG00000260578.1 |
Imatinib |
Esophageal cancer |
0.023344004 |
Sensitive |
| ENSG00000267172.1 |
Imatinib |
Esophageal cancer |
0.028473231 |
Sensitive |
| ENSG00000267201.1 |
Imatinib |
Esophageal cancer |
0.017715933 |
Sensitive |
| ENSG00000267640.1 |
Imatinib |
Esophageal cancer |
0.003656774 |
Sensitive |
| ENSG00000272172.1 |
Imatinib |
Esophageal cancer |
0.003581032 |
Sensitive |
| ENSG00000180139.10 |
Imatinib |
Brain lower grade glioma |
0.030994118 |
Sensitive |
| ENSG00000186019.10 |
Imatinib |
Brain lower grade glioma |
0.020729725 |
Sensitive |
| ENSG00000196553.9 |
Imatinib |
Brain lower grade glioma |
0.013175624 |
Sensitive |
| ENSG00000206028.1 |
Imatinib |
Brain lower grade glioma |
0.030337423 |
Sensitive |
| ENSG00000214770.2 |
Imatinib |
Brain lower grade glioma |
0.04117703 |
Sensitive |
| ENSG00000214851.4 |
Imatinib |
Brain lower grade glioma |
0.046371122 |
Sensitive |
| ENSG00000215190.4 |
Imatinib |
Brain lower grade glioma |
0.03907324 |
Sensitive |
| ENSG00000215447.3 |
Imatinib |
Brain lower grade glioma |
0.023666437 |
Sensitive |
| ENSG00000222043.2 |
Imatinib |
Brain lower grade glioma |
0.004317334 |
Sensitive |
| ENSG00000223692.1 |
Imatinib |
Brain lower grade glioma |
0.020341494 |
Sensitive |
| ENSG00000223768.1 |
Imatinib |
Brain lower grade glioma |
0.010975793 |
Sensitive |
| ENSG00000224043.3 |
Imatinib |
Brain lower grade glioma |
0.024564771 |
Sensitive |
| ENSG00000224086.3 |
Imatinib |
Brain lower grade glioma |
0.043259146 |
Sensitive |
| ENSG00000224216.1 |
Imatinib |
Brain lower grade glioma |
0.028554375 |
Sensitive |
| ENSG00000224223.1 |
Imatinib |
Brain lower grade glioma |
0.037897505 |
Sensitive |
| ENSG00000224276.1 |
Imatinib |
Brain lower grade glioma |
0.006072119 |
Sensitive |
| ENSG00000224533.3 |
Imatinib |
Brain lower grade glioma |
0.008765791 |
Sensitive |
| ENSG00000224790.1 |
Imatinib |
Brain lower grade glioma |
0.015454479 |
Sensitive |
| ENSG00000224844.1 |
Imatinib |
Brain lower grade glioma |
0.044780555 |
Sensitive |
| ENSG00000224914.2 |
Imatinib |
Brain lower grade glioma |
0.03471554 |
Sensitive |
| ENSG00000224977.1 |
Imatinib |
Brain lower grade glioma |
0.012125186 |
Sensitive |
| ENSG00000225376.1 |
Imatinib |
Brain lower grade glioma |
0.035098464 |
Sensitive |
| ENSG00000225393.1 |
Imatinib |
Brain lower grade glioma |
0.041343586 |
Sensitive |
| ENSG00000225555.1 |
Imatinib |
Brain lower grade glioma |
0.021914394 |
Sensitive |
| ENSG00000225783.2 |
Imatinib |
Brain lower grade glioma |
0.030903946 |
Sensitive |
| ENSG00000226245.1 |
Imatinib |
Brain lower grade glioma |
0.027274422 |
Sensitive |
| ENSG00000226877.3 |
Imatinib |
Brain lower grade glioma |
0.016336939 |
Sensitive |
| ENSG00000226944.1 |
Imatinib |
Brain lower grade glioma |
0.044367971 |
Sensitive |
| ENSG00000227245.1 |
Imatinib |
Brain lower grade glioma |
0.042899036 |
Sensitive |
| ENSG00000227352.1 |
Imatinib |
Brain lower grade glioma |
0.043691729 |
Sensitive |
| ENSG00000227354.2 |
Imatinib |
Brain lower grade glioma |
0.035500274 |
Sensitive |
| ENSG00000227627.1 |
Imatinib |
Brain lower grade glioma |
0.025077959 |
Sensitive |
| ENSG00000227704.1 |
Imatinib |
Brain lower grade glioma |
0.025512793 |
Sensitive |
| ENSG00000228016.1 |
Imatinib |
Brain lower grade glioma |
0.009534675 |
Sensitive |
| ENSG00000228135.1 |
Imatinib |
Brain lower grade glioma |
0.026181998 |
Sensitive |
| ENSG00000228137.1 |
Imatinib |
Brain lower grade glioma |
0.038259161 |
Sensitive |
| ENSG00000228389.1 |
Imatinib |
Brain lower grade glioma |
0.011659705 |
Sensitive |
| ENSG00000228486.5 |
Imatinib |
Brain lower grade glioma |
0.007862654 |
Sensitive |
| ENSG00000228817.3 |
Imatinib |
Brain lower grade glioma |
0.02351796 |
Sensitive |
| ENSG00000228906.1 |
Imatinib |
Brain lower grade glioma |
0.002174809 |
Sensitive |
| ENSG00000229589.1 |
Imatinib |
Brain lower grade glioma |
0.04816091 |
Sensitive |
| ENSG00000229751.1 |
Imatinib |
Brain lower grade glioma |
0.036428603 |
Sensitive |
| ENSG00000230303.1 |
Imatinib |
Brain lower grade glioma |
0.013076428 |
Sensitive |
| ENSG00000230366.5 |
Imatinib |
Brain lower grade glioma |
0.015316953 |
Sensitive |
| ENSG00000230536.1 |
Imatinib |
Brain lower grade glioma |
0.012241055 |
Sensitive |
| ENSG00000230552.1 |
Imatinib |
Brain lower grade glioma |
0.048225851 |
Sensitive |
| ENSG00000230565.1 |
Imatinib |
Brain lower grade glioma |
0.020089459 |
Sensitive |
| ENSG00000230699.2 |
Imatinib |
Brain lower grade glioma |
0.000655087 |
Sensitive |
| ENSG00000231154.1 |
Imatinib |
Brain lower grade glioma |
0.019912548 |
Sensitive |
| ENSG00000231612.1 |
Imatinib |
Brain lower grade glioma |
0.006547408 |
Sensitive |
| ENSG00000231616.4 |
Imatinib |
Brain lower grade glioma |
0.034453994 |
Sensitive |
| ENSG00000231728.2 |
Imatinib |
Brain lower grade glioma |
0.039866005 |
Sensitive |
| ENSG00000232118.1 |
Imatinib |
Brain lower grade glioma |
0.001715569 |
Sensitive |
| ENSG00000232354.3 |
Imatinib |
Brain lower grade glioma |
0.029716267 |
Sensitive |
| ENSG00000232520.1 |
Imatinib |
Brain lower grade glioma |
0.01792164 |
Sensitive |
| ENSG00000232618.1 |
Imatinib |
Brain lower grade glioma |
0.039173276 |
Sensitive |
| ENSG00000232638.1 |
Imatinib |
Brain lower grade glioma |
0.046377435 |
Sensitive |
| ENSG00000232640.1 |
Imatinib |
Brain lower grade glioma |
0.023740832 |
Sensitive |
| ENSG00000232973.7 |
Imatinib |
Brain lower grade glioma |
0.037374905 |
Sensitive |
| ENSG00000233108.1 |
Imatinib |
Brain lower grade glioma |
0.039862417 |
Sensitive |
| ENSG00000233757.2 |
Imatinib |
Brain lower grade glioma |
0.023356251 |
Sensitive |
| ENSG00000235100.3 |
Imatinib |
Brain lower grade glioma |
0.048491751 |
Sensitive |
| ENSG00000235296.1 |
Imatinib |
Brain lower grade glioma |
0.022558939 |
Sensitive |
| ENSG00000235335.2 |
Imatinib |
Brain lower grade glioma |
0.03538998 |
Sensitive |
| ENSG00000235410.1 |
Imatinib |
Brain lower grade glioma |
0.019775148 |
Sensitive |
| ENSG00000235494.1 |
Imatinib |
Brain lower grade glioma |
0.020760517 |
Sensitive |
| ENSG00000235545.1 |
Imatinib |
Brain lower grade glioma |
0.036685207 |
Sensitive |
| ENSG00000235903.3 |
Imatinib |
Brain lower grade glioma |
0.020863165 |
Sensitive |
| ENSG00000236051.2 |
Imatinib |
Brain lower grade glioma |
0.010049518 |
Sensitive |
| ENSG00000236404.4 |
Imatinib |
Brain lower grade glioma |
0.04582216 |
Sensitive |
| ENSG00000236432.3 |
Imatinib |
Brain lower grade glioma |
0.006915717 |
Sensitive |
| ENSG00000236463.1 |
Imatinib |
Brain lower grade glioma |
0.005481507 |
Sensitive |
| ENSG00000236833.1 |
Imatinib |
Brain lower grade glioma |
0.035162241 |
Sensitive |
| ENSG00000236901.3 |
Imatinib |
Brain lower grade glioma |
0.041763303 |
Sensitive |
| ENSG00000237756.1 |
Imatinib |
Brain lower grade glioma |
0.016750133 |
Sensitive |
| ENSG00000237838.1 |
Imatinib |
Brain lower grade glioma |
0.022301162 |
Sensitive |
| ENSG00000237976.1 |
Imatinib |
Brain lower grade glioma |
0.021138029 |
Sensitive |
| ENSG00000238123.1 |
Imatinib |
Brain lower grade glioma |
0.04610335 |
Sensitive |
| ENSG00000238141.2 |
Imatinib |
Brain lower grade glioma |
0.022529004 |
Sensitive |
| ENSG00000239462.1 |
Imatinib |
Brain lower grade glioma |
0.029508603 |
Sensitive |
| ENSG00000240050.1 |
Imatinib |
Brain lower grade glioma |
0.01097872 |
Sensitive |
| ENSG00000240758.2 |
Imatinib |
Brain lower grade glioma |
0.004091841 |
Sensitive |
| ENSG00000241180.1 |
Imatinib |
Brain lower grade glioma |
0.001612229 |
Sensitive |
| ENSG00000241219.1 |
Imatinib |
Brain lower grade glioma |
0.045125768 |
Sensitive |
| ENSG00000242553.1 |
Imatinib |
Brain lower grade glioma |
0.002686442 |
Sensitive |
| ENSG00000242622.1 |
Imatinib |
Brain lower grade glioma |
0.023873165 |
Sensitive |
| ENSG00000242791.2 |
Imatinib |
Brain lower grade glioma |
0.00488204 |
Sensitive |
| ENSG00000243350.1 |
Imatinib |
Brain lower grade glioma |
0.042678344 |
Sensitive |
| ENSG00000243533.2 |
Imatinib |
Brain lower grade glioma |
0.011959597 |
Sensitive |
| ENSG00000244625.1 |
Imatinib |
Brain lower grade glioma |
0.033887535 |
Sensitive |
| ENSG00000245685.2 |
Imatinib |
Brain lower grade glioma |
0.043378253 |
Sensitive |
| ENSG00000246465.1 |
Imatinib |
Brain lower grade glioma |
0.025746998 |
Sensitive |
| ENSG00000246560.2 |
Imatinib |
Brain lower grade glioma |
0.041822987 |
Sensitive |
| ENSG00000246792.2 |
Imatinib |
Brain lower grade glioma |
0.021166723 |
Sensitive |
| ENSG00000246859.2 |
Imatinib |
Brain lower grade glioma |
0.027720597 |
Sensitive |
| ENSG00000246877.1 |
Imatinib |
Brain lower grade glioma |
0.040036948 |
Sensitive |
| ENSG00000247516.3 |
Imatinib |
Brain lower grade glioma |
0.008128018 |
Sensitive |
| ENSG00000247572.3 |
Imatinib |
Brain lower grade glioma |
0.041658438 |
Sensitive |
| ENSG00000248240.1 |
Imatinib |
Brain lower grade glioma |
0.042083477 |
Sensitive |
| ENSG00000248476.1 |
Imatinib |
Brain lower grade glioma |
0.027005628 |
Sensitive |
| ENSG00000249085.1 |
Imatinib |
Brain lower grade glioma |
0.034255316 |
Sensitive |
| ENSG00000249430.1 |
Imatinib |
Brain lower grade glioma |
0.031159311 |
Sensitive |
| ENSG00000249610.1 |
Imatinib |
Brain lower grade glioma |
0.02326347 |
Sensitive |
| ENSG00000249635.1 |
Imatinib |
Brain lower grade glioma |
0.022209584 |
Sensitive |
| ENSG00000249655.1 |
Imatinib |
Brain lower grade glioma |
0.049258502 |
Sensitive |
| ENSG00000250132.2 |
Imatinib |
Brain lower grade glioma |
0.020798371 |
Sensitive |
| ENSG00000250220.1 |
Imatinib |
Brain lower grade glioma |
0.02341146 |
Sensitive |
| ENSG00000250240.1 |
Imatinib |
Brain lower grade glioma |
0.036285691 |
Sensitive |
| ENSG00000250802.2 |
Imatinib |
Brain lower grade glioma |
0.03095073 |
Sensitive |
| ENSG00000250948.1 |
Imatinib |
Brain lower grade glioma |
0.031963172 |
Sensitive |
| ENSG00000251034.1 |
Imatinib |
Brain lower grade glioma |
0.012623307 |
Sensitive |
| ENSG00000251054.1 |
Imatinib |
Brain lower grade glioma |
0.020729644 |
Sensitive |
| ENSG00000251141.1 |
Imatinib |
Brain lower grade glioma |
0.004730523 |
Sensitive |
| ENSG00000251613.3 |
Imatinib |
Brain lower grade glioma |
0.01036639 |
Sensitive |
| ENSG00000253559.1 |
Imatinib |
Brain lower grade glioma |
0.032526107 |
Sensitive |
| ENSG00000253865.1 |
Imatinib |
Brain lower grade glioma |
0.04357011 |
Sensitive |
| ENSG00000254035.1 |
Imatinib |
Brain lower grade glioma |
0.046120121 |
Sensitive |
| ENSG00000254207.1 |
Imatinib |
Brain lower grade glioma |
0.045390229 |
Sensitive |
| ENSG00000254510.1 |
Imatinib |
Brain lower grade glioma |
0.019331484 |
Sensitive |
| ENSG00000254990.1 |
Imatinib |
Brain lower grade glioma |
0.047398071 |
Sensitive |
| ENSG00000255310.2 |
Imatinib |
Brain lower grade glioma |
0.003531501 |
Sensitive |
| ENSG00000255669.1 |
Imatinib |
Brain lower grade glioma |
0.012354929 |
Sensitive |
| ENSG00000256360.1 |
Imatinib |
Brain lower grade glioma |
0.041303478 |
Sensitive |
| ENSG00000257696.1 |
Imatinib |
Brain lower grade glioma |
0.012691223 |
Sensitive |
| ENSG00000257999.1 |
Imatinib |
Brain lower grade glioma |
0.031413253 |
Sensitive |
| ENSG00000258441.1 |
Imatinib |
Brain lower grade glioma |
0.026440274 |
Sensitive |
| ENSG00000258471.1 |
Imatinib |
Brain lower grade glioma |
0.049366293 |
Sensitive |
| ENSG00000258766.1 |
Imatinib |
Brain lower grade glioma |
0.009775737 |
Sensitive |
| ENSG00000258825.1 |
Imatinib |
Brain lower grade glioma |
0.035148035 |
Sensitive |
| ENSG00000259039.1 |
Imatinib |
Brain lower grade glioma |
0.016339861 |
Sensitive |
| ENSG00000259153.1 |
Imatinib |
Brain lower grade glioma |
0.008544149 |
Sensitive |
| ENSG00000259172.1 |
Imatinib |
Brain lower grade glioma |
0.023282423 |
Sensitive |
| ENSG00000259548.1 |
Imatinib |
Brain lower grade glioma |
0.017161801 |
Sensitive |
| ENSG00000259635.1 |
Imatinib |
Brain lower grade glioma |
0.036675262 |
Sensitive |
| ENSG00000259954.1 |
Imatinib |
Brain lower grade glioma |
0.046443949 |
Sensitive |
| ENSG00000260006.1 |
Imatinib |
Brain lower grade glioma |
0.030913723 |
Sensitive |
| ENSG00000260176.1 |
Imatinib |
Brain lower grade glioma |
0.043358016 |
Sensitive |
| ENSG00000260186.1 |
Imatinib |
Brain lower grade glioma |
0.006761049 |
Sensitive |
| ENSG00000260293.1 |
Imatinib |
Brain lower grade glioma |
0.03588984 |
Sensitive |
| ENSG00000260361.1 |
Imatinib |
Brain lower grade glioma |
0.016188518 |
Sensitive |
| ENSG00000260420.1 |
Imatinib |
Brain lower grade glioma |
0.047041452 |
Sensitive |
| ENSG00000260614.1 |
Imatinib |
Brain lower grade glioma |
0.048943413 |
Sensitive |
| ENSG00000260804.2 |
Imatinib |
Brain lower grade glioma |
0.037613414 |
Sensitive |
| ENSG00000260830.1 |
Imatinib |
Brain lower grade glioma |
0.021927432 |
Sensitive |
| ENSG00000260831.1 |
Imatinib |
Brain lower grade glioma |
0.049601949 |
Sensitive |
| ENSG00000260874.1 |
Imatinib |
Brain lower grade glioma |
0.047352888 |
Sensitive |
| ENSG00000260884.1 |
Imatinib |
Brain lower grade glioma |
0.040718558 |
Sensitive |
| ENSG00000260927.1 |
Imatinib |
Brain lower grade glioma |
0.032826271 |
Sensitive |
| ENSG00000260931.1 |
Imatinib |
Brain lower grade glioma |
0.029644714 |
Sensitive |
| ENSG00000260949.1 |
Imatinib |
Brain lower grade glioma |
0.012551493 |
Sensitive |
| ENSG00000261140.1 |
Imatinib |
Brain lower grade glioma |
0.04206757 |
Sensitive |
| ENSG00000261167.1 |
Imatinib |
Brain lower grade glioma |
0.00450102 |
Sensitive |
| ENSG00000261288.1 |
Imatinib |
Brain lower grade glioma |
0.036096995 |
Sensitive |
| ENSG00000261428.1 |
Imatinib |
Brain lower grade glioma |
0.037139135 |
Sensitive |
| ENSG00000261447.1 |
Imatinib |
Brain lower grade glioma |
0.033254872 |
Sensitive |
| ENSG00000261533.1 |
Imatinib |
Brain lower grade glioma |
0.003801879 |
Sensitive |
| ENSG00000261613.2 |
Imatinib |
Brain lower grade glioma |
0.044761403 |
Sensitive |
| ENSG00000261670.1 |
Imatinib |
Brain lower grade glioma |
0.047150693 |
Sensitive |
| ENSG00000261673.1 |
Imatinib |
Brain lower grade glioma |
0.036691939 |
Sensitive |
| ENSG00000261770.1 |
Imatinib |
Brain lower grade glioma |
0.043630279 |
Sensitive |
| ENSG00000261839.1 |
Imatinib |
Brain lower grade glioma |
0.031005676 |
Sensitive |
| ENSG00000262172.1 |
Imatinib |
Brain lower grade glioma |
0.04441395 |
Sensitive |
| ENSG00000262721.1 |
Imatinib |
Brain lower grade glioma |
0.01702436 |
Sensitive |
| ENSG00000263011.1 |
Imatinib |
Brain lower grade glioma |
0.0323339 |
Sensitive |
| ENSG00000263220.1 |
Imatinib |
Brain lower grade glioma |
0.017845758 |
Sensitive |
| ENSG00000263551.1 |
Imatinib |
Brain lower grade glioma |
0.023472726 |
Sensitive |
| ENSG00000264167.1 |
Imatinib |
Brain lower grade glioma |
0.035010084 |
Sensitive |
| ENSG00000264520.1 |
Imatinib |
Brain lower grade glioma |
0.040384862 |
Sensitive |
| ENSG00000264735.1 |
Imatinib |
Brain lower grade glioma |
0.009906552 |
Sensitive |
| ENSG00000265443.1 |
Imatinib |
Brain lower grade glioma |
0.042595615 |
Sensitive |
| ENSG00000267152.1 |
Imatinib |
Brain lower grade glioma |
0.032928 |
Sensitive |
| ENSG00000267167.1 |
Imatinib |
Brain lower grade glioma |
0.046636085 |
Sensitive |
| ENSG00000267231.1 |
Imatinib |
Brain lower grade glioma |
0.027394601 |
Sensitive |
| ENSG00000267588.2 |
Imatinib |
Brain lower grade glioma |
0.042745976 |
Sensitive |
| ENSG00000267613.1 |
Imatinib |
Brain lower grade glioma |
0.033620933 |
Sensitive |
| ENSG00000267898.1 |
Imatinib |
Brain lower grade glioma |
0.007198372 |
Sensitive |
| ENSG00000268015.1 |
Imatinib |
Brain lower grade glioma |
0.022874027 |
Sensitive |
| ENSG00000268049.1 |
Imatinib |
Brain lower grade glioma |
0.035367562 |
Sensitive |
| ENSG00000268262.1 |
Imatinib |
Brain lower grade glioma |
0.04766932 |
Sensitive |
| ENSG00000268912.1 |
Imatinib |
Brain lower grade glioma |
0.007591398 |
Sensitive |
| ENSG00000269220.1 |
Imatinib |
Brain lower grade glioma |
0.033469795 |
Sensitive |
| ENSG00000269918.1 |
Imatinib |
Brain lower grade glioma |
0.004902417 |
Sensitive |
| ENSG00000269959.1 |
Imatinib |
Brain lower grade glioma |
0.022820831 |
Sensitive |
| ENSG00000269983.1 |
Imatinib |
Brain lower grade glioma |
0.007580294 |
Sensitive |
| ENSG00000270018.1 |
Imatinib |
Brain lower grade glioma |
0.007496298 |
Sensitive |
| ENSG00000270091.1 |
Imatinib |
Brain lower grade glioma |
0.030871005 |
Sensitive |
| ENSG00000270223.1 |
Imatinib |
Brain lower grade glioma |
0.004475697 |
Sensitive |
| ENSG00000270599.1 |
Imatinib |
Brain lower grade glioma |
0.045719593 |
Sensitive |
| ENSG00000270996.1 |
Imatinib |
Brain lower grade glioma |
0.047110791 |
Sensitive |
| ENSG00000271009.2 |
Imatinib |
Brain lower grade glioma |
0.030421189 |
Sensitive |
| ENSG00000271147.3 |
Imatinib |
Brain lower grade glioma |
0.025432486 |
Sensitive |
| ENSG00000271265.1 |
Imatinib |
Brain lower grade glioma |
0.038085804 |
Sensitive |
| ENSG00000271659.1 |
Imatinib |
Brain lower grade glioma |
0.049022794 |
Sensitive |
| ENSG00000271757.1 |
Imatinib |
Brain lower grade glioma |
0.044047868 |
Sensitive |
| ENSG00000271782.1 |
Imatinib |
Brain lower grade glioma |
0.00245919 |
Sensitive |
| ENSG00000271927.1 |
Imatinib |
Brain lower grade glioma |
0.032912651 |
Sensitive |
| ENSG00000272029.1 |
Imatinib |
Brain lower grade glioma |
0.022218461 |
Sensitive |
| ENSG00000272070.1 |
Imatinib |
Brain lower grade glioma |
0.021859639 |
Sensitive |
| ENSG00000272103.1 |
Imatinib |
Brain lower grade glioma |
0.020698956 |
Sensitive |
| ENSG00000272137.1 |
Imatinib |
Brain lower grade glioma |
0.036551698 |
Sensitive |
| ENSG00000272250.1 |
Imatinib |
Brain lower grade glioma |
0.029935057 |
Sensitive |
| ENSG00000272263.1 |
Imatinib |
Brain lower grade glioma |
0.02886913 |
Sensitive |
| ENSG00000272301.1 |
Imatinib |
Brain lower grade glioma |
0.03037451 |
Sensitive |
| ENSG00000272308.1 |
Imatinib |
Brain lower grade glioma |
0.005572716 |
Sensitive |
| ENSG00000272335.1 |
Imatinib |
Brain lower grade glioma |
0.013650333 |
Sensitive |
| ENSG00000272354.1 |
Imatinib |
Brain lower grade glioma |
0.039795236 |
Sensitive |
| ENSG00000272379.1 |
Imatinib |
Brain lower grade glioma |
0.036459675 |
Sensitive |
| ENSG00000272438.1 |
Imatinib |
Brain lower grade glioma |
0.015625688 |
Sensitive |
| ENSG00000272461.1 |
Imatinib |
Brain lower grade glioma |
0.017517189 |
Sensitive |
| ENSG00000272498.1 |
Imatinib |
Brain lower grade glioma |
0.023341211 |
Sensitive |
| ENSG00000272631.1 |
Imatinib |
Brain lower grade glioma |
0.020831405 |
Sensitive |
| ENSG00000272682.1 |
Imatinib |
Brain lower grade glioma |
0.029410654 |
Sensitive |
| ENSG00000272690.1 |
Imatinib |
Brain lower grade glioma |
0.001591354 |
Sensitive |
| ENSG00000272791.1 |
Imatinib |
Brain lower grade glioma |
0.042021062 |
Sensitive |
| ENSG00000272798.1 |
Imatinib |
Brain lower grade glioma |
0.038963939 |
Sensitive |
| ENSG00000272828.1 |
Imatinib |
Brain lower grade glioma |
0.023680443 |
Sensitive |
| ENSG00000272942.1 |
Imatinib |
Brain lower grade glioma |
0.043771568 |
Sensitive |
| ENSG00000272966.1 |
Imatinib |
Brain lower grade glioma |
0.029742308 |
Sensitive |
| ENSG00000273017.1 |
Imatinib |
Brain lower grade glioma |
0.046433453 |
Sensitive |
| ENSG00000273056.1 |
Imatinib |
Brain lower grade glioma |
0.001336185 |
Sensitive |
| ENSG00000273156.1 |
Imatinib |
Brain lower grade glioma |
0.046724735 |
Sensitive |
| ENSG00000273181.1 |
Imatinib |
Brain lower grade glioma |
0.028944436 |
Sensitive |
| ENSG00000273190.1 |
Imatinib |
Brain lower grade glioma |
0.004632749 |
Sensitive |
| ENSG00000273306.1 |
Imatinib |
Brain lower grade glioma |
0.016880058 |
Sensitive |
| ENSG00000273372.1 |
Imatinib |
Brain lower grade glioma |
0.048352777 |
Sensitive |
| ENSG00000273399.1 |
Imatinib |
Brain lower grade glioma |
0.038793716 |
Sensitive |
| ENSG00000273402.1 |
Imatinib |
Brain lower grade glioma |
0.048703448 |
Sensitive |
| ENSG00000273454.1 |
Imatinib |
Brain lower grade glioma |
0.017243945 |
Sensitive |
| ENSG00000273473.1 |
Imatinib |
Brain lower grade glioma |
0.020154977 |
Sensitive |
| ENSG00000167912.5 |
Imatinib |
Lung squamous cell carcinoma |
0.023211457 |
Sensitive |
| ENSG00000213904.4 |
Imatinib |
Lung squamous cell carcinoma |
0.040078705 |
Sensitive |
| ENSG00000224020.1 |
Imatinib |
Lung squamous cell carcinoma |
0.046540219 |
Sensitive |
| ENSG00000224093.1 |
Imatinib |
Lung squamous cell carcinoma |
0.033829644 |
Sensitive |
| ENSG00000224596.3 |
Imatinib |
Lung squamous cell carcinoma |
0.041399047 |
Sensitive |
| ENSG00000225138.3 |
Imatinib |
Lung squamous cell carcinoma |
0.019033445 |
Sensitive |
| ENSG00000226330.1 |
Imatinib |
Lung squamous cell carcinoma |
0.010725323 |
Sensitive |
| ENSG00000227036.2 |
Imatinib |
Lung squamous cell carcinoma |
0.004748164 |
Sensitive |
| ENSG00000228084.1 |
Imatinib |
Lung squamous cell carcinoma |
0.038474442 |
Sensitive |
| ENSG00000228857.2 |
Imatinib |
Lung squamous cell carcinoma |
0.044808954 |
Sensitive |
| ENSG00000230084.1 |
Imatinib |
Lung squamous cell carcinoma |
0.037825015 |
Sensitive |
| ENSG00000231121.2 |
Imatinib |
Lung squamous cell carcinoma |
0.025717983 |
Sensitive |
| ENSG00000231217.1 |
Imatinib |
Lung squamous cell carcinoma |
0.028491536 |
Sensitive |
| ENSG00000231346.1 |
Imatinib |
Lung squamous cell carcinoma |
0.044231206 |
Sensitive |
| ENSG00000231969.1 |
Imatinib |
Lung squamous cell carcinoma |
0.015041569 |
Sensitive |
| ENSG00000231976.3 |
Imatinib |
Lung squamous cell carcinoma |
0.038422344 |
Sensitive |
| ENSG00000232536.1 |
Imatinib |
Lung squamous cell carcinoma |
0.040815095 |
Sensitive |
| ENSG00000232686.1 |
Imatinib |
Lung squamous cell carcinoma |
0.038894384 |
Sensitive |
| ENSG00000233080.2 |
Imatinib |
Lung squamous cell carcinoma |
0.023264376 |
Sensitive |
| ENSG00000233251.3 |
Imatinib |
Lung squamous cell carcinoma |
0.040992648 |
Sensitive |
| ENSG00000233895.1 |
Imatinib |
Lung squamous cell carcinoma |
0.047439506 |
Sensitive |
| ENSG00000234617.1 |
Imatinib |
Lung squamous cell carcinoma |
0.040572077 |
Sensitive |
| ENSG00000234678.1 |
Imatinib |
Lung squamous cell carcinoma |
0.025981794 |
Sensitive |
| ENSG00000235138.1 |
Imatinib |
Lung squamous cell carcinoma |
0.015942846 |
Sensitive |
| ENSG00000235397.1 |
Imatinib |
Lung squamous cell carcinoma |
0.036406357 |
Sensitive |
| ENSG00000236526.1 |
Imatinib |
Lung squamous cell carcinoma |
0.025185218 |
Sensitive |
| ENSG00000236824.1 |
Imatinib |
Lung squamous cell carcinoma |
0.019210056 |
Sensitive |
| ENSG00000236869.1 |
Imatinib |
Lung squamous cell carcinoma |
0.021778472 |
Sensitive |
| ENSG00000236977.1 |
Imatinib |
Lung squamous cell carcinoma |
0.03988477 |
Sensitive |
| ENSG00000237073.1 |
Imatinib |
Lung squamous cell carcinoma |
0.026355356 |
Sensitive |
| ENSG00000237416.2 |
Imatinib |
Lung squamous cell carcinoma |
0.02293642 |
Sensitive |
| ENSG00000237805.1 |
Imatinib |
Lung squamous cell carcinoma |
0.046804104 |
Sensitive |
| ENSG00000237883.1 |
Imatinib |
Lung squamous cell carcinoma |
0.040181438 |
Sensitive |
| ENSG00000238018.1 |
Imatinib |
Lung squamous cell carcinoma |
0.018873825 |
Sensitive |
| ENSG00000238272.1 |
Imatinib |
Lung squamous cell carcinoma |
0.034945423 |
Sensitive |
| ENSG00000241990.1 |
Imatinib |
Lung squamous cell carcinoma |
0.037560601 |
Sensitive |
| ENSG00000242258.1 |
Imatinib |
Lung squamous cell carcinoma |
0.025955206 |
Sensitive |
| ENSG00000243144.2 |
Imatinib |
Lung squamous cell carcinoma |
0.015840743 |
Sensitive |
| ENSG00000245573.3 |
Imatinib |
Lung squamous cell carcinoma |
0.039359755 |
Sensitive |
| ENSG00000245598.2 |
Imatinib |
Lung squamous cell carcinoma |
0.040807864 |
Sensitive |
| ENSG00000247134.2 |
Imatinib |
Lung squamous cell carcinoma |
0.037046006 |
Sensitive |
| ENSG00000247556.2 |
Imatinib |
Lung squamous cell carcinoma |
0.030220891 |
Sensitive |
| ENSG00000248677.1 |
Imatinib |
Lung squamous cell carcinoma |
0.046704961 |
Sensitive |
| ENSG00000249593.2 |
Imatinib |
Lung squamous cell carcinoma |
0.03288312 |
Sensitive |
| ENSG00000250410.1 |
Imatinib |
Lung squamous cell carcinoma |
0.00089172 |
Sensitive |
| ENSG00000251432.2 |
Imatinib |
Lung squamous cell carcinoma |
0.018755461 |
Sensitive |
| ENSG00000253955.1 |
Imatinib |
Lung squamous cell carcinoma |
0.042043809 |
Sensitive |
| ENSG00000254459.1 |
Imatinib |
Lung squamous cell carcinoma |
0.031334902 |
Sensitive |
| ENSG00000255160.1 |
Imatinib |
Lung squamous cell carcinoma |
0.039877843 |
Sensitive |
| ENSG00000255176.1 |
Imatinib |
Lung squamous cell carcinoma |
0.021164791 |
Sensitive |
| ENSG00000257660.1 |
Imatinib |
Lung squamous cell carcinoma |
0.023002642 |
Sensitive |
| ENSG00000258458.1 |
Imatinib |
Lung squamous cell carcinoma |
0.047092106 |
Sensitive |
| ENSG00000258904.1 |
Imatinib |
Lung squamous cell carcinoma |
0.046465893 |
Sensitive |
| ENSG00000259158.1 |
Imatinib |
Lung squamous cell carcinoma |
0.032488964 |
Sensitive |
| ENSG00000259244.1 |
Imatinib |
Lung squamous cell carcinoma |
0.011897812 |
Sensitive |
| ENSG00000259345.1 |
Imatinib |
Lung squamous cell carcinoma |
0.035844847 |
Sensitive |
| ENSG00000259712.1 |
Imatinib |
Lung squamous cell carcinoma |
0.047422207 |
Sensitive |
| ENSG00000259783.1 |
Imatinib |
Lung squamous cell carcinoma |
0.019169463 |
Sensitive |
| ENSG00000259953.1 |
Imatinib |
Lung squamous cell carcinoma |
0.044449007 |
Sensitive |
| ENSG00000260034.1 |
Imatinib |
Lung squamous cell carcinoma |
0.012741338 |
Sensitive |
| ENSG00000261654.1 |
Imatinib |
Lung squamous cell carcinoma |
0.049934012 |
Sensitive |
| ENSG00000263220.1 |
Imatinib |
Lung squamous cell carcinoma |
0.037811908 |
Sensitive |
| ENSG00000263680.2 |
Imatinib |
Lung squamous cell carcinoma |
0.004800592 |
Sensitive |
| ENSG00000264937.1 |
Imatinib |
Lung squamous cell carcinoma |
0.035799311 |
Sensitive |
| ENSG00000265218.1 |
Imatinib |
Lung squamous cell carcinoma |
0.039904587 |
Sensitive |
| ENSG00000265282.1 |
Imatinib |
Lung squamous cell carcinoma |
0.027879955 |
Sensitive |
| ENSG00000266644.1 |
Imatinib |
Lung squamous cell carcinoma |
0.035985333 |
Sensitive |
| ENSG00000267565.1 |
Imatinib |
Lung squamous cell carcinoma |
0.020726802 |
Sensitive |
| ENSG00000267934.1 |
Imatinib |
Lung squamous cell carcinoma |
0.019964335 |
Sensitive |
| ENSG00000268266.1 |
Imatinib |
Lung squamous cell carcinoma |
0.048307061 |
Sensitive |
| ENSG00000268583.1 |
Imatinib |
Lung squamous cell carcinoma |
0.014373217 |
Sensitive |
| ENSG00000268756.1 |
Imatinib |
Lung squamous cell carcinoma |
0.032571977 |
Sensitive |
| ENSG00000269102.1 |
Imatinib |
Lung squamous cell carcinoma |
0.002336151 |
Sensitive |
| ENSG00000269653.1 |
Imatinib |
Lung squamous cell carcinoma |
0.036226009 |
Sensitive |
| ENSG00000269956.1 |
Imatinib |
Lung squamous cell carcinoma |
0.009604991 |
Sensitive |
| ENSG00000270039.1 |
Imatinib |
Lung squamous cell carcinoma |
0.00888714 |
Sensitive |
| ENSG00000270704.2 |
Imatinib |
Lung squamous cell carcinoma |
0.031770098 |
Sensitive |
| ENSG00000272024.1 |
Imatinib |
Lung squamous cell carcinoma |
0.01733995 |
Sensitive |
| ENSG00000272070.1 |
Imatinib |
Lung squamous cell carcinoma |
0.01796547 |
Sensitive |
| ENSG00000272076.1 |
Imatinib |
Lung squamous cell carcinoma |
0.032717511 |
Sensitive |
| ENSG00000272088.1 |
Imatinib |
Lung squamous cell carcinoma |
0.035424317 |
Sensitive |
| ENSG00000272940.1 |
Imatinib |
Lung squamous cell carcinoma |
0.036805145 |
Sensitive |
| ENSG00000273448.1 |
Imatinib |
Lung squamous cell carcinoma |
0.016057067 |
Sensitive |
